Antihypertensive and antioxidant effects of dietary black sesame meal in pre-hypertensive humans

Nutrition Journal

Naruemon Leelayuwat⁴  Nuchanart Rangkadilok⁸  Yaovalak Teerajetgul⁶  Suchart Sirijaichingkul³  Nantarat Komanasin⁹  Nongnuch Settasatian⁶  Chatri Settasatian⁵  Patcharee Boonsiri¹  Natthida Weerapreeyakul²  Jatuporn Wichitsranoi⁷ 

[1] Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand;Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand;Department of Clinical Immunology, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand;Department of Physiology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand;Department of Pathology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand;Department of Clinical Chemistry, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand;Faculty of Physical Therapy, Mahidol University, Nakhon Pathom 73170, Thailand;Laboratory of Pharmacology, Chulabhorn Research Institute (CRI), Vibhavadee-Rangsit Highway, Laksi, Bangkok 10210, Thailand;Department of Clinical Microscopy, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand

关键词: tocopherol;    sesamolin;    sesamin;    malondialdehyde;    oxidative stress;    blood pressure;   

Others  :  828957
DOI  :  10.1186/1475-2891-10-82

 received in 2011-03-11, accepted in 2011-08-09,  发布年份 2011

【 摘 要 】

Background

It has been known that hypertension is an independent risk factor for cardiovascular disease (CVD). CVD is the major cause of morbidity and mortality in developed and developing countries. Elevation of blood pressure (BP) increases the adverse effect for cardiovascular outcomes. Prevention of increased BP plays a crucial role in a reduction of those outcomes, leading to a decrease in mortality. Therefore, the purpose of this study was to investigate the effects of dietary black sesame meal on BP and oxidative stress in individuals with prehypertension.

Methods

Twenty-two women and eight men (aged 49.8 ± 6.6 years) with prehypertension were randomly divided into two groups, 15 subjects per group. They ingested 2.52 g black sesame meal capsules or placebo capsules each day for 4 weeks. Blood samples were obtained after overnight fasting for measurement of plasma lipid, malondialdehyde (MDA) and vitamin E levels. Anthropometry, body composition and BP were measured before and after 4-week administration of black sesame meal or a placebo.

Results

The results showed that 4-week administration of black sesame meal significantly decreased systolic BP (129.3 ± 6.8 vs. 121.0 ± 9.0 mmHg, P < 0.05) and MDA level (1.8 ± 0.6 vs. 1.2 ± 0.6 μmol/L, P < 0.05), and increased vitamin E level (29.4 ± 6.0 vs. 38.2 ± 7.8 μmol/L, P < 0.01). In the black sesame meal group, the change in SBP tended to be positively related to the change in MDA (R = 0.50, P = 0.05), while the change in DBP was negatively related to the change in vitamin E (R = -0.55, P < 0.05). There were no correlations between changes in BP and oxidative stress in the control group.

Conclusions

These results suggest the possible antihypertensive effects of black sesame meal on improving antioxidant status and decreasing oxidant stress. These data may imply a beneficial effect of black sesame meal on prevention of CVD.

【 授权许可】

   
2011 Wichitsranoi et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 2.

Figure 3.

【 参考文献 】

• [1]Japanese Society of Hypertension: Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2004). Hypertens Res 2006, 29(Suppl):S1-S105.
• [2]Dhalla NS, Temsah RM, Netticadan T: Role of oxidative stress in cardiovascular diseases. J Hypertens 2000, 18:655-673.
• [3]Cooney RV, Custer LJ, Okinaka L, Franke AA: Effects of dietary sesame seeds on plasma tocopherol levels. Nutr Cancer 2001, 39:66-71.
• [4]Ikeda S, Kagaya M, Kobayashi K, Tohyama T, Kiso Y, Higuchi N, Yamashita K: Dietary sesame lignans decrease lipid peroxidation in rats fed docosahexaenoic acid. J Nutr Sci Vitaminol (Tokyo) 2003, 49:270-276.
• [5]Kang MH, Naito M, Tsujihara N, Osawa T: Sesamolin inhibits lipid peroxidation in rat liver and kidney. J Nutr 1998, 128:1018-1022.
• [6]Nakai M, Harada M, Nakahara K, Akimoto K, Shibata H, Miki W, Kiso Y: Novel antioxidative metabolites in rat liver with ingested sesamin. J Agric Food Chem 2003, 51:1666-1670.
• [7]Yamashita K, Iizuka Y, Imai T, Namiki M: Sesame seed and its lignans produce marked enhancement of vitamin E activity in rats fed a low alpha-tocopherol diet. Lipids 1995, 30:1019-1028.
• [8]Boshtam M, Rafiei M, Sadeghi K, Sarraf-Zadegan N: Vitamin E can reduce blood pressure in mild hypertensives. Int J Vitam Nutr Res 2002, 72:309-314.
• [9]Miyawaki T, Aono H, Toyoda-Ono Y, Maeda H, Kiso Y, Moriyama K: Antihypertensive effects of sesamin in humans. J Nutr Sci Vitaminol (Tokyo) 2009, 55:87-91.
• [10]Sankar D, Rao MR, Sambandam G, Pugalendi KV: Effect of sesame oil on diuretics or β-blockers in the modulation of blood pressure, anthropometry, lipid profile, and redox status. Yale J Biol Med 2006, 79:19-26.
• [11]Sankar D, Sambandam G, Rao MR, Pugalendi KV: Modulation of blood pressure, lipid profiles and redox status in hypertensive patients taking different edible oils. Clin Chim Acta 2005, 355:97-104.
• [12]Ward NC, Wu JH, Clarke MW, Puddey IB, Burke V, Croft KD, Hodgson JM: The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. J Hypertens 2007, 25:227-234.
• [13]Economides PA, Khaodhiar L, Caselli A, Caballero AE, Keenan H, Bursell SE, King GL, Johnstone MT, Horton RS, Veves A: The effect of vitamin E on endothelial function of micro- and macrocirculation and left ventricular function in type 1 and type 2 diabetic patients. Diabetes 2005, 54:204-211.
• [14]Palumbo G, Avanzini F, Alli C, Roncaglioni MC, Ronchi E, Cristofari M, Capra A, Rossi S, Nosotti L, Costantini C, Cavalera C: Effects of vitamin E on clinic and ambulatory blood pressure in treated hypertensive patients. Collaborative Group of the Primary Prevention Project (PPP) - Hypertension study. Am J Hypertens 2000, 5(Pt 1):564-567.
• [15]Brigelius-Flohé R: Vitamin E and drug metabolism. Biochem Biophys Res Commun 2003, 305:737-740.
• [16]Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 2003, 289:2560-2571.
• [17]Kontush A, Spranger T, Reich A, Baum K, Beisiegel U: Lipophilic antioxidants in blood plasma as markers of atherosclerosis: the role of alpha-carotene and gamma-tocopherol. Atherosclerosis 1999, 144:117-122.
• [18]Institute of Medicine, Food and Nutrition Board: Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academy Press; 2000.
• [19]Rangkadilok N, Pholphana N, Mahidol C, Wongyai W, Saengsooksree K, Nookabkaew S, Satayavivad J: Variation of sesamin, sesamolin and tocopherols in sesame (Sesamum indicum L.) seeds and oil products in Thailand. Food Chemistry 2010, 122:724-730.
• [20]Draper HH, Squires EJ, Mahmoodi H, Wu J, Agarwal S, Hadley M: A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radic Biol Med 1993, 15:353-363.
• [21]Thurnham DI, Smith E, Flora PS: Concurrent liquid-chromatographic assay of retinol, alpha-tocopherol, beta-carotene, alpha-carotene, lycopene, and beta-cryptoxanthin in plasma, with tocopherol acetate as internal standard. Clin Chem 1988, 34:377-381.
• [22]Stamler J, Rose G, Stamler R, Elliott P, Dyer A, Marmot M: INTERSALT study finding: public health and medical care implications. Hypertension 1989, 14:570-577.
• [23]Noguchi T, Ikeda K, Sasaki Y, Yamamoto J, Yamori Y: Effects of vitamin E and sesamin on hypertension and cerebral thrombogenesis in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 2004, 31(Suppl 2):24-26.
• [24]Kamal-Eldin A, Frank J, Razdan A, Tengblad S, Basu S, Vessby B: Effects of dietary phenolic compounds on tocopherol, cholesterol, and fatty acids in rats. Lipids 2000, 35:427-435.
• [25]Ikeda S, Abe C, Uchida T, Ichikawa T, Horio F, Yamashita K: Dietary sesame seed and its lignan increase both ascorbic acid concentration in some tissues and urinary excretion by stimulating biosynthesis in rats. J Nutr Sci Vitaminol (Tokyo) 2007, 53:383-392.
• [26]Ito H, Torii M, Suzuki T: Comparative study on free radical injury in the endothelium of SHR and WKY aorta. Clin Exp Pharmacol Physiol 1995, 22(Suppl 2):157-159.
• [27]Thomas SR, Chen K, Keaney JF Jr: Oxidative stress and endothelial nitric oxide bioactivity. Antioxid Redox Signal 2003, 5:181-194.
• [28]Ward NC, Hodgson JM, Puddey IB, Mori TA, Beilin LJ, Croft KD: Oxidative stress in human hypertension: association with antihypertensive treatment, gender, nutrition, and lifestyle. Free Radical Biol Med 2004, 36:226-232.
• [29]Li D, Saldeen T, Romeo F, Mehta JL: Relative effects of alpha- and gamma-tocopherol on low-density lipoprotein oxidation and superoxide dismutase and nitric oxide synthase activity and protein expression in rats. J Cardiovasc Pharmacol Ther 1999, 4:219-226.
• [30]van Aalst JA, Burmeister W, Fox PL, Graham LM: Alpha-tocopherol preserves endothelial cell migration in the presence of cell-oxidized low-density lipoprotein by inhibiting changes in cell membrane fluidity. J Vasc Surg 2004, 39:229-237.
• [31]Pezeshk A, Derick Dalhouse A: Vitamin E, membrane fluidity, and blood pressure in hypertensive and normotensive rats. Life Sci 2000, 67:1881-1889.
• [32]Lee CC, Chen PR, Lin S, Tsai SC, Wang BW, Chen WW, Tsai CE, Shyu KG: Sesamin induces nitric oxide and decreases endothelin-1 production in HUVECs: possible implications for its antihypertensive effect. J Hypertens 2004, 22:2329-2338.
• [33]Wu JH, Hodgson JM, Clarke MW, Indrawan AP, Barden AE, Puddey IB, Croft KD: Inhibition of 20-hydroxyeicosatetraenoic acid synthesis using specific plant lignans: in vitro and human studies. Hypertension 2009, 54:1151-1158.
• [34]Nakano D, Kwak CJ, Fujii K, Ikemura K, Satake A, Ohkita M, Takaoka M, Ono Y, Nakai M, Tomimori N, Kiso Y, Matsumura Y: Sesamin metabolites induce an endothelial nitric oxide-dependent vasorelaxation through their antioxidative property-independent mechanisms: possible involvement of the metabolites in the antihypertensive effect of sesamin. J Pharmacol Exp Ther 2006, 318:328-335.